SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-036294
Filing Date
2022-06-30
Accepted
2022-06-30 16:15:13
Documents
12
Period of Report
2022-06-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 ea162323-8k_oramedpharma.htm   iXBRL 8-K 40279
  Complete submission text file 0001213900-22-036294.txt   213981

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ormp-20220630.xsd EX-101.SCH 2998
3 XBRL LABEL FILE ormp-20220630_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ormp-20220630_pre.xml EX-101.PRE 22385
6 EXTRACTED XBRL INSTANCE DOCUMENT ea162323-8k_oramedpharma_htm.xml XML 3612
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 221058204
SIC: 2834 Pharmaceutical Preparations